Stine Kjellev is Vice President, Drug Discovery at ALK-Abelló, a global pharmaceutical company focused on allergy prevention, diagnosis, and treatment. She has a strong background in drug discovery and preclinical development within immunological and hematological indications. Stine has more than 20 years of experience in the pharmaceutical industry spanning from large-scale companies to start-ups. Stine is Doctor of Veterinary Medicine and holds a PhD in immunopharmacology from the University of Copenhagen.

Stine serves as an Observer to Allegria’s Board of Directors, contributing extensive expertise in immunology and the discovery of novel therapies for allergic diseases.

Connect on LinkedIn.